Cargando…
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Co-expression of chimeric switch receptors (CSRs) specific for PD-L1 improves the antitumor effects of chimeric antigen receptor (CAR) T cells. However, the effects of trans-recognition between CSRs and PD-L1 expressed by activated CAR T cells remain unclear. Here, we design a CSR specific for PD-L1...
Autores principales: | Qin, Le, Cui, Yuanbin, Yuan, Tingjie, Chen, Dongmei, Zhao, Ruocong, Li, Shanglin, Jiang, Zhiwu, Wu, Qiting, Long, Youguo, Wang, Suna, Tang, Zhaoyang, Pan, Huixia, Li, Xiaoping, Wei, Wei, Yang, Jie, Luo, Xuequn, Zhang, Zhenfeng, Tang, Qiannan, Liu, Pentao, Weinkove, Robert, Yao, Yao, Qin, Dajiang, Thiery, Jean Paul, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561169/ https://www.ncbi.nlm.nih.gov/pubmed/36229619 http://dx.doi.org/10.1038/s41467-022-33793-w |
Ejemplares similares
-
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D
por: Li, Shanglin, et al.
Publicado: (2022) -
Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021) -
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
por: Zheng, Diwei, et al.
Publicado: (2022) -
Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer
por: Zhao, Ruocong, et al.
Publicado: (2021) -
DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells
por: Zhao, Ruocong, et al.
Publicado: (2018)